129 related articles for article (PubMed ID: 38699697)
21. Presence of elevated carcinoembryonic antigen on absorbent disks applied to nipple area of breast carcinoma patients.
Imayama S; Mori M; Ueo H; Nanbara S; Adachi Y; Mimori K; Shimozono Y; Hori Y; Sugimachi K
Cancer; 1996 Sep; 78(6):1229-34. PubMed ID: 8826944
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an improved dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge in early breast cancer: results of a multicenter study.
Mori T; Inaji H; Koyama H; Abe R; Nihei M; Izuo M; Ogawa T; Enomoto K; Sato H; Kasumi F
Jpn J Clin Oncol; 1992 Dec; 22(6):371-6. PubMed ID: 1291755
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Values of Carcinoembryonic Antigen, Cancer Antigen 15-3 and Cancer Antigen 125 Levels in Nipple Discharge.
Zhao S; Gai X; Wang Y; Liang W; Gao H; Zhang K; Wang H; Liu Y; Wang J; Ma R
Chin J Physiol; 2015 Dec; 58(6):385-92. PubMed ID: 26717917
[TBL] [Abstract][Full Text] [Related]
24. Correlation of Molecular Tumor Markers CA125, HE4, and CEA with the Development and Progression of Epithelial Ovarian Cancer.
Wan Q; Liu Y; Lv B; Chen X
Iran J Public Health; 2021 Jun; 50(6):1197-1205. PubMed ID: 34540740
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
[TBL] [Abstract][Full Text] [Related]
26. Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction.
Jia L; Li G; Ma N; Zhang A; Zhou Y; Ren L; Dong D
BMC Cancer; 2022 Jul; 22(1):760. PubMed ID: 35831854
[TBL] [Abstract][Full Text] [Related]
27. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
[TBL] [Abstract][Full Text] [Related]
28. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
29. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
Lellé RJ; Henkel E; Leinemann D; Goeschen K
Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
[TBL] [Abstract][Full Text] [Related]
30. Surgical outcomes of total duct excision in the diagnosis and management of nipple discharge.
Ward K; Selvarajah G; Al-Omishy H; Sait M; Khan HN; McEvoy K; Robertson S
Ann R Coll Surg Engl; 2024 Mar; ():. PubMed ID: 38497796
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of serum biomarkers CA153, CEA, and white blood cells in predicting sentinel lymph node metastasis of breast cancer.
Fan Y; Chen X; Li H
Int J Clin Exp Pathol; 2020; 13(11):2889-2894. PubMed ID: 33284901
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
Zheng H; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
[TBL] [Abstract][Full Text] [Related]
34. Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors.
Chen F; Shen J; Wang J; Cai P; Huang Y
Cancer Manag Res; 2018; 10():1313-1318. PubMed ID: 29861641
[TBL] [Abstract][Full Text] [Related]
35. The "Trunk sign": A novel X-ray sign in galactography of patients with nipple discharge suggesting malignancy.
Wu T; Zhang K; Wang Y; Ma R
Medicine (Baltimore); 2023 Aug; 102(32):e34589. PubMed ID: 37565883
[TBL] [Abstract][Full Text] [Related]
36. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract][Full Text] [Related]
37. Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy.
Zhang Y; Zhao J; Wang Y; Cai W; Zhang X; Li K; Liu W; Zhao Y; Kang H
Dis Markers; 2022; 2022():7739777. PubMed ID: 35634442
[TBL] [Abstract][Full Text] [Related]
38. ErbB-2 protein levels in nipple discharge: role in diagnosis of early breast cancer.
Inaji H; Koyama H; Motomura K; Noguchi S; Mori Y; Kimura Y; Sugano K; Ohkura H
Tumour Biol; 1993; 14(5):271-8. PubMed ID: 7901888
[TBL] [Abstract][Full Text] [Related]
39. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
[TBL] [Abstract][Full Text] [Related]
40. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
